TRGNF
TRANSGENE S.A. by TRANSGENE S.A. (TRGNF)
$00
About TRANSGENE S.A. by TRANSGENE S.A. (TRGNF)
Transgene SA is a biotechnology company that focuses on designing and developing targeted immunotherapies for the treatment of cancer. Its products include TG4001, TG4050, TG6002, BT-001 & TG6050. The company was founded in December 1979 and is headquartered in Strasbourg, France.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.59
52 Week Low
$0.70
Market cap
273.9M
Dividend yield
0.00%
Volume
--
Avg. volume
132
P/E ratio
-3.31
TRANSGENE S.A. by TRANSGENE S.A. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.59
52 Week Low
$0.70
Market cap
273.9M
Dividend yield
0.00%
Volume
--
Avg. volume
132
P/E ratio
-3.31